Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CRY2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
WDFY2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
P2RX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OGFOD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDK12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBFOX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BHLHE40 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LAMC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAPN15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC6A8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP8B4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR91 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCRN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MED31 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HS1BP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BORCS8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAP30L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on